An international consensus article establishes clinical trial design in liver cancer
Researchers from the Cancer Area at IDIBAPS and the Clínic Barcelona Comprehensive Cancer Centre have led the development of an international conse...
Researchers from the Cancer Area at IDIBAPS and the Clínic Barcelona Comprehensive Cancer Centre have led the development of an international conse...
Researchers from Clínic-IDIBAPS have participated in a study published in Nature Reviews Cancer that reviews how fat-associated liver diseases, kno...
To mark the 25th anniversary of a landmark framework in cancer research, Cell has published a special issue devoted to the biological processes tha...
Liver fibrosis results from chronic liver damage and can progress silently over many years, without obvious symptoms, until liver injury becomes ir...
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clín...
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer...
Funded by the Spanish Association Against Cancer (AECC) and coordinated by IDIBAPS and the Salamanca Cancer Research Centre, ASPIRE-AECC aims to im...
A team of researchers from the Clínic-IDIBAPS have analysed the capacity of an artificial intelligence model to classify liver lesions after a magn...
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet...
Researchers from the Hospital Clínic-IDIBAPS have participated in the preparation of the new guidelines on intrahepatic cholangiocarcinoma, the sec...